HYLAVISC Trademark

Trademark Overview

On Sunday, August 20, 2017, a trademark application was filed for HYLAVISC with the United States Patent and Trademark Office. The USPTO has given the HYLAVISC trademark a serial number of 87576073. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 12, 2021. This trademark is owned by Matrix Biology Institute. The HYLAVISC trademark is filed in the Pharmaceutical Products category with the following description:

Hyaluronic acid for pharmaceutical purposes
hylavisc

General Information

Serial Number87576073
Word MarkHYLAVISC
Filing DateSunday, August 20, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and ServicesHyaluronic acid for pharmaceutical purposes
Pseudo MarkHYLA VISC

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMatrix Biology Institute
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEdgewater, NJ 07020
Party NameMatrix Biology Institute
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEdgewater, NJ 07020

Trademark Events

Event DateEvent Description
Monday, April 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2020EXTENSION 5 GRANTED
Tuesday, September 8, 2020EXTENSION 5 FILED
Thursday, September 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2020TEAS EXTENSION RECEIVED
Tuesday, March 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 28, 2020EXTENSION 4 GRANTED
Friday, February 28, 2020EXTENSION 4 FILED
Friday, February 28, 2020TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2019EXTENSION 3 GRANTED
Friday, August 30, 2019EXTENSION 3 FILED
Friday, August 30, 2019TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2019EXTENSION 2 GRANTED
Friday, March 1, 2019EXTENSION 2 FILED
Friday, March 1, 2019TEAS EXTENSION RECEIVED
Saturday, August 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 23, 2018EXTENSION 1 GRANTED
Thursday, August 23, 2018EXTENSION 1 FILED
Thursday, August 23, 2018TEAS EXTENSION RECEIVED
Tuesday, March 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 25, 2017ASSIGNED TO EXAMINER
Thursday, August 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, August 23, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

hylavisc purposes pharmaceutical acid hyaluronic